Toxicological interactions may occur not only when exposure to two or more chemicals is simultaneous, but also when exposures are separated in time. Often the sequence of exposure determines the nature of the toxicological response. This is illustrated with the two hindered phenolic antioxidants, butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA). Evidence available suggests that in certain tissues exposure to BHT first and then to i l carcinogen is without significant consequences, whereas exposure to BHT after a carcinogen may enhance tumor formation. O n the other hand, exposure to BHA before carcinogen administration often has a protective effect, whereas exposure to BHA after a carcinogen sometimes protects and sometimes is without any influence. Mechanisms underlying these interactions may be induction of mixed function oxidases, production of cell hyperplasia or other, as yet ill-defined, events such as modification of biological reactivity.
TOXICOLOGICAL INTERACTIONS
Toxicological interactions have been defined, although somewhat clumsily, as "a circumstance in which exposure to two or more chemicals results in a qualitatively or quan-titativeIy altered biological response relative to that predicted from the actions of the chemical singly. The multiple-chemical exposures may be simultaneous or sequential in time and the altered response may be greater or smaller in magnitude." (1) as the molecular sites for absorption, activation, detoxification, injurious action or excretion. On the other hand, when exposure to two different agents is separated in time, the first agent may produce, in a given tissue, multiple cellular or molecular changes which eventually profoundly modify the subsequent biological response to a second agent even if the first agent is no longer present. Among interactions of this type we may list foremost the induction of mixed function oxidases by a first chemical with subsequent modification of the metabolism of other agents. This can enhance toxicity or afford some protection, depending on how metabolic pathways shift. Two-stage carcinogenesis is another example where exposure to two agents, first to the initiator and then to the promoter, produces a profoundly altered biological response, provided again exposure is sequential and occurs in a strictly ordered sequence. A more detailed analysis of the principles underlying toxicological interactions is available (2). 
The importance of the temporal sequence of exposure to two agents can be iIlustrated with a series of experiments on the development of lung tumors in mice. In the strain A mouse, a single injection of 1000 mg/kg of urethan will produce, within 4-6 months, an average of 20 tumors per lung (3). Approximately 80% of these tumors are derived from the type I1 epithelial cells of the alveolar walls. Some years ago it was observed that intraperitoneal injection or oral administration of the antioxidant butylated hydroxytoluene (BHT) produces within a few days a substantial hyperplasia of type I1 alveolar cells in mouse lung (4). This observation led us to speculate that BHT, given repeatedly after a carcinogenic dose of urethan, would increase the number of lung tumors. The rationale for this speculation was that agents capable of repeatedly producing cell hyperplasia in liver or skin had been found to enhance the development of hepatic or epidermal tumors. On the other hand, if given before a carcinogen, BMT which also is a good inducer of mixed function oxidases might alter carcinogen metabolism and the result could be a decrease or perhaps no change in number of tumors formed. Figure 1 summarizes some of the ob&rvations made. BHT fed at a concentratioxi'of 0.75% in the diet for 2 weeks before treating A/J mice with urethan will not enhance tumor development, whether the feeding with BHT continues after injection of the carcinogen or it is discontinued. However, if urethan is injected first and BHT administration begun 24 hours later, more tumors will develop compared to animals not fed BHT. FIG. 2-Male A/J mice were injected with urethan and, 24 hrs later, given 0.75% BHT in the diet for 1, 2, 3,4, 8, or 12 weeks. After BHT exposure, the animals were returned to conventional laboratory diet and were killed 4 months after urethan. BHT dose refers to cumulative dose of BHT ingested during experiment. Data from Witschi and Morse (5). ure 2 shows that the length of exposure to BHT is of some importance. One week on a 0.75% BHT diet has no significant effect, whereas 2 weeks are already enough to significantly enhance lung tumor development.
A maximum effect appears to be reached with 8-12 weeks feeding of the antioxidant (5).
Duration of exposure to BHT is not the only determining variable. Figure 3 shows that a BHT concentration of 0.1% (1000 ppm) in the diet is enough to significantly enhance tumor development, provided exposure lasts for 8 weeks. Finally, it has been found that BHT not only enhances the development of tumors produced in mouse lung by urethan, but also by benzo(a)pyrene, 3-methylcholanthrene or dimet hylnitrosamine, regardless of whether BHT is.incorporated in the diet or injected intraperitoneally ( Figure 4 ) (6, 7). In summary, it is possible to enhance significantly the development of lung tumors in mice by BHT, provided exposure to BHT occurs after the administration of a carcinogen. Given alone, BHT has never been found to produce an increased incidence or multiplicity of lung tumors in A/J mice.
HYDROXYANISOLE
Butylated hydroxyanisole (BHA) is structurally closely related to BHT. It also is a good inducer of mixed function oxidases in the liver. In the lung. BHA does not produce cell hyperplasia. We have recently shown that if 110th BHT and UHA are fed to mice at a concentration 0.75% only BHT produces an increased labelling of pulmonary parenchymal cells, whereas BHA is without any effect (8). In previous experiments it was found that BHA does not enhance tumor formation in the lungs of mice treated with urethan (6). The data in figure 5 show some interesting differences between BHT and BHA. If animals are fed 0.75% BHT for two weeks and then injected with urethan, the same number of tumors will develop as in animals not given any BHT. However, in animals prefed 0.75% BHA for two weeks and then treated with either urethan or benzo(a)pyrene, fewer tumors (less than half of the number found in controls) will develop; data on what happens if animals are prefed with BHT and then treated with benzo(a)pyrene are not available yet. In other words, so far it has been established that pretreatment with BHA protects animals against lung tumor formation, whereas BHT has not been found to have such a protective effect. However, if animals qre treated first with benzo(a)pyrene or urethan and then fed BHT (0.75% for 8 weeks), tumor development is enhanced. Feeding of BHA after urethan has no effect, and in animals treated with benzo(a)pyrene and then fed 0.75% BHA in the diet for 8 weeks significantly fewer tumors were found. In other words, in animals exposed to benzo(a)pyrene (300 mg/kg by stomach tube) BHA was found to protect against tumor formation regardless of whether .the animals were given the antioxidant before or after the carcinogen, whereas with urethan this effect was only observed in animals prefed with BHA.
TtiE JANUS HEADS OF BHT AND BHA
A large body of experimental data has consistently shown that BHA, if fed or injected into animals before exposure to a carcinogen, conveys a certain protection against the developments of chemically induced tumors at several sites (9) . It was commonly assumed that this effect could be attributed to the induction of mixed function oxidases in liver and other tissues; qualitative and quantitative shifts in carcinogen metabolism would follow and influence tumor development. In our own experiments we recently found that UHA is able to reduce the number of lung tumors in A/J mice if animals are fed the antioxidant not only before, but also after they have been exposed to benzo(a)pg,rene ( Figure 5 ). A similar finding indicated 'that 0.5% BHA in the diet would protect female Sprague-Dawley rats against development of mammary carcinogenesis induced by 7.12dimethylbenzanthracene (DIMBA) and this even if exposure to BHA was begun only one week after the carcinogen had been given (10) . Both experiments need to be repeated and expanded; however they point to the exciting possibility that it might be possible to influence tumor development not only by modification of metabolism prior to carcinogen exposure, but also by other, as yet unexplored means. On the other hand it has been found that life-long exposure to,BHA in the diet Significantly .increases the incidence of malignant forestomach tumors in F344 rats (11) . To what extent this will offset the beneficial effects of BHA remains to be seen.
Somewhat similar observations ivere made with BHT. Many early studies showed that exposure to BHT before or concomitantly with a toxic agent gave a certain protection against chemical carcinogenesis or mutagenesis; BHT also prolonged survival of mice and rats (12) . However it was also found that administration of BHT after a hepatocarcinogen significantly increased the number of liver tumors (13) or that it may even act as a liver carcinogen (14). It was also shown that concomitant exposure to N-2-fluorenylacetamide (FAA) and BHT inhibits the induction of liver tumors, but enhances the development of bladder tumors (15), whereas it apparently can diminish mammary tumors induced by DiMBA (10).
In conclusion, both hindered phenolic antioxidants (BHA and BHT) have been found to have desirable (protection against chemical carcinogenesis) or undesirable (enhancement or promotion of tumor formation or frank carcinogenesis) properties in a variety of biological systems. If we are concerned aa WITSCHI about their safety as food additives, then we clearly face a next to impossible choice, simply because we do not have any clues at all whether or not in man, and under present conditions of exposure, the desirable or the undesirable properties of BHT and BHA are more likely to prevail. However, if we look on these compounds as valuable research tools then it becomes obvious that they have opened up numerous important biological questions about principles underlying interactions between chemicals and their targets. These questions should be worthwhile to explore in years to come.
